ARCHIVES

Patient Costs In Trials Should Be Paid In Any Reform Plan, DCT Board Write To Shalala

This article is from The Cancer Letter archive.

Vol. 19 No. 25 | June 18, 1993

Download PDF Visit The Full Archive

Related Articles

Eight Probable Minority CCOP Awardees Lister; NCI May Award As Many As 12, With 220 Payline

June 1, 1990

Drugs and Targets: Cyramza approved in metastatic stomach cancer

November 7, 2014

Critics of FDA misunderstand Bayesian analysis, statisticians say.

August 5, 2005

Study Begins On Link Between Down Syndrome, Leukemia

May 28, 2004

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

In Brief: Baltimore Names ACS Research Professor; Currie, Sachdeva Lead Education Association

December 9, 1994